1. Home
  2. XOMA vs CUB Comparison

XOMA vs CUB Comparison

Compare XOMA & CUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • CUB
  • Stock Information
  • Founded
  • XOMA 1981
  • CUB 2024
  • Country
  • XOMA United States
  • CUB United States
  • Employees
  • XOMA N/A
  • CUB N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • CUB
  • Sector
  • XOMA Health Care
  • CUB
  • Exchange
  • XOMA Nasdaq
  • CUB NYSE
  • Market Cap
  • XOMA 294.2M
  • CUB 315.9M
  • IPO Year
  • XOMA N/A
  • CUB 2024
  • Fundamental
  • Price
  • XOMA $25.02
  • CUB $10.36
  • Analyst Decision
  • XOMA Strong Buy
  • CUB
  • Analyst Count
  • XOMA 2
  • CUB 0
  • Target Price
  • XOMA $69.50
  • CUB N/A
  • AVG Volume (30 Days)
  • XOMA 18.4K
  • CUB 33.5K
  • Earning Date
  • XOMA 05-20-2025
  • CUB 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • CUB N/A
  • EPS Growth
  • XOMA N/A
  • CUB N/A
  • EPS
  • XOMA N/A
  • CUB N/A
  • Revenue
  • XOMA $28,487,000.00
  • CUB N/A
  • Revenue This Year
  • XOMA $17.89
  • CUB N/A
  • Revenue Next Year
  • XOMA $34.58
  • CUB N/A
  • P/E Ratio
  • XOMA N/A
  • CUB $45.34
  • Revenue Growth
  • XOMA 498.72
  • CUB N/A
  • 52 Week Low
  • XOMA $18.35
  • CUB $9.96
  • 52 Week High
  • XOMA $35.00
  • CUB $10.55
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 65.43
  • CUB N/A
  • Support Level
  • XOMA $22.91
  • CUB N/A
  • Resistance Level
  • XOMA $25.17
  • CUB N/A
  • Average True Range (ATR)
  • XOMA 1.09
  • CUB 0.00
  • MACD
  • XOMA 0.11
  • CUB 0.00
  • Stochastic Oscillator
  • XOMA 100.00
  • CUB 0.00

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About CUB LIONHEART HOLDINGS

Lionheart Holdings is a blank check company.

Share on Social Networks: